Paper Details

Paper Title

NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer.

Paper Journal Title

Oncotarget

Paper Citation Count

Paper Publication Year

2014

Bio Mention

ATM, ATR, DDR genes, DDR-sensing gene, MRE11A, NBN, NBN gene, Nibrin, PCa, PCa cells, PRKDC, PSA, RAD50, RadP, localized, localized prostate cancers, patients, prostate cancer, tumour

Mesh Descriptor

Biomarkers, Tumor, Cell Cycle Proteins, Comparative Genomic Hybridization, DNA Damage, Disease-Free Survival, Genomic Instability, Humans, Male, Nuclear Proteins, Precision Medicine, Predictive Value of Tests, Prostatectomy, Prostatic Neoplasms, Radiation Tolerance, Radiotherapy, Image-Guided, Treatment Outcome

Author Name	Affiliation
Alejandro Berlin	University of Toronto, Princess Margaret Cancer Centre, University Health Network
Emilie Lalonde	University of Toronto, Ontario Institute for Cancer Research
Jenna Sykes	University of Toronto
Gaetano Zafarana	University of Toronto
Kenneth C Chu	University of Toronto, Ontario Institute for Cancer Research
Varune R Ramnarine	University of British Columbia
Adrian Ishkanian	University of Toronto, Princess Margaret Cancer Centre, University Health Network
Dorota H Sendorek	University of Toronto
Ivan Pasic	University of Toronto
Wan L Lam	University of British Columbia, British Columbia Cancer Research Centre
Igor Jurisica	The Techna Institute, University Health Network
Theodorus H van der Kwast	University of Toronto
Michael Milosevic	University of Toronto, Princess Margaret Cancer Centre, University Health Network
Paul C Boutros	University of Toronto, Ontario Institute for Cancer Research
Robert G Bristow	University of Toronto, Princess Margaret Cancer Centre, University Health Network

1 - 15

Paper Details

Column Actions

Datasets